0.000USD0.000Pre-market 07/02, 09:30 (ET)
633.57KMarket Cap
43.10P/E TTM
Protagenic Therapeutics Inc
You can access the annual and quarterly cash flow statements of Protagenic Therapeutics Inc to evaluate its financial soundness and stability.
FAQs
What is the cash flow statement?
This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.